Search Results 1571-1580 of 12481 for Birth Control Palette
... population PK. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of ...
This is a multicenter, two-arm, randomized, double-blind, placebo-controlled study of Optune® (Tumor Treating Fields at 200 kHz) together with maintenance ...
The Placebo-Controlled Efficacy in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is an investigation of cerebrospinal fluid (CSF) ...
Ivan Porter, M.D.. Closed for enrollment. More information. Publications. A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177 ...
... controlled type 2 diabetes mellitus (T2D) in primary care settings through a randomized clinical trial. Participation eligibility. Participant eligibility ...
... population. Complete recovery from surgery. Registration to A081801 must be 30-77 days following surgery. No prior neoadjuvant or adjuvant therapy for ...
About this study. An important means to control the COVID-19 pandemic is the rapid identification of infected individuals to allow quarantine and therapy to ...
This is a randomized, double-blind, placebo-controlled parallel group outpatient study that will utilize standard stroke rehabilitation outcome measures, as ...
... controlled diabetes. History of autoimmune disease considered clinically significant or requiring chronic steroid or immune suppression medication. History ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.